The results showed reduced mRNA levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in the liver of the NASH mice, indicating the therapeutic potential of QRQZ on NASH [64]. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.